参考文献：
[1]Maldonado, V.V., Patel, N.H., Smith, E.E. et al. Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy. J Biol Eng 17, 44 (2023). https://doi.org/10.1186/s13036-023-00361-9
链接：https://link.springer.com/article/10.1186/s13036-023-00361-9#citeas
[2] Xia S, Zhang X, Zheng S, Khanabdali R, Kalionis B, Wu J, Wan W, Tai X. An Update on Inflamm-Aging: Mechanisms, Prevention, and Treatment. J Immunol Res. 2016;2016:8426874. doi: 10.1155/2016/8426874IF: 3.5 Q2 . Epub 2016 Jul 14. PMID: 27493973; PMCID: PMC4963991.
链接：https://pmc.ncbi.nlm.nih.gov/articles/PMC4963991/
[3] Nguyen, NH.T., Phan, H.T., Le, P.M. et al. Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial. Trials 25, 309 (2024).
链接：https://doi.org/10.1186/s13063-024-08128-3
[4]Prockop, Darwin J, and Joo Youn Oh. “Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation.” Molecular therapy : the journal of the American Society of Gene Therapy vol. 20,1 (2012): 14-20. doi:10.1038/mt.2011.211
链接：https://pubmed.ncbi.nlm.nih.gov/22008910/
